Molecular and Clinical Studies of Primary Immunodeficiency Diseases

计划入组 266 人 · 首次发布于 2000 年 10 月 2 日

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

计划入组 50 人 · 首次发布于 2006 年 1 月 19 日

Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases

计划入组 38 人 · 首次发布于 2013 年 6 月 24 日

intravenous immunoglobulin (primary immunodeficiency disease)

Primary sclerosing cholangitis(Engitix )

primary immunization-booster TB vaccine

PRIMARY PHARMACEUTICALS, INC.

United States

PRIMARY HEALTH CARE CORPORATION

Qatar

Southcoast Center For Primary & Specialty Care

United States

Subcutaneous Immunoglobulin 20% Effective for Primary Immunodeficiency

Kedrion Biopharma Secures FDA Approval for QIVIGY, First Proprietary IVIG Therapy for Primary Immunodeficiency

mRNA Delivery to CD34+ Cells via Lipid Nanoparticles Shows Promise in Rhesus Monkeys